Cargando…
Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis
OBJECTIVE: DNA methylation is the earliest and most studied epigenetic modification in cancer. The literature reported that the abnormal methylation level of multiple genes was associated with poor prognosis in ovarian cancer. However, due to a small sample size, the results reported in the literatu...
Autores principales: | Feng, Li-yuan, Chen, Chang-xian, Li, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408028/ https://www.ncbi.nlm.nih.gov/pubmed/30813180 http://dx.doi.org/10.1097/MD.0000000000014588 |
Ejemplares similares
-
Arsenic exposure is associated with DNA hypermethylation of the tumor suppressor gene p16
por: Lu, Guangming, et al.
Publicado: (2014) -
Significance of Hypermethylation of Tumor-Suppressor Genes PTGER4 and ZNF43 at CpG Sites in the Prognosis of Colorectal Cancer
por: Chen, Chao-Yang, et al.
Publicado: (2022) -
Hypermethylation of DHRS3 as a Novel Tumor Suppressor Involved in Tumor Growth and Prognosis in Gastric Cancer
por: Sumei, Sha, et al.
Publicado: (2021) -
Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients
por: Chou, Jian-Liang, et al.
Publicado: (2015) -
Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis
por: Shen, Na, et al.
Publicado: (2019)